These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25747927)

  • 61. Barriers to implementing evidence-based practices in addiction treatment programs: comparing staff reports on Motivational Interviewing, Adolescent Community Reinforcement Approach, Assertive Community Treatment, and Cognitive-behavioral Therapy.
    Amodeo M; Lundgren L; Cohen A; Rose D; Chassler D; Beltrame C; D'Ippolito M
    Eval Program Plann; 2011 Nov; 34(4):382-9. PubMed ID: 21420171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Addiction research centres and the nurturing of creativity. The Chinese National Institute on Drug Dependence, Peking University: past, present and future.
    Wang X; Zhao D; Shi J; Zhao C; Liu Z; Lu L
    Addiction; 2010 Sep; 105(9):1525-30. PubMed ID: 20491722
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inability to access addiction treatment among street-involved youth in a Canadian setting.
    Phillips M; DeBeck K; Desjarlais T; Morrison T; Feng C; Kerr T; Wood E
    Subst Use Misuse; 2014 Aug; 49(10):1233-40. PubMed ID: 24621085
    [TBL] [Abstract][Full Text] [Related]  

  • 64. National Institutes of Health. Collins endorses merger of U.S. addiction research programs.
    Kaiser J
    Science; 2010 Nov; 330(6008):1166. PubMed ID: 21109640
    [No Abstract]   [Full Text] [Related]  

  • 65. Enhancing transitions from addiction treatment to primary care.
    Cucciare MA; Coleman EA; Saitz R; Timko C
    J Addict Dis; 2014; 33(4):340-53. PubMed ID: 25299380
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Addiction research centres and the nurturing of creativity: IFT Institut für Therapieforschung in Munich, Germany.
    Bühringer G
    Addiction; 2014 Aug; 109(8):1245-51. PubMed ID: 24903425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Addiction research centres and the nurturing of creativity: the Department of Alcohol, Drugs and Addiction at the National Institute for Health and Welfare in Finland: diverse problems, diverse perspectives.
    Hakkarainen P; Kiianmaa K; Kuoppasalmi K; Tigerstedt C
    Addiction; 2012 Oct; 107(10):1741-6. PubMed ID: 21992550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Performance measures for substance use disorders--what research is needed?
    Garnick DW; Horgan CM; Acevedo A; McCorry F; Weisner C
    Addict Sci Clin Pract; 2012 Sep; 7(1):18. PubMed ID: 23186374
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Global research mapping of substance use disorder and treatment 1971-2017: implications for priority setting.
    Tran BX; Moir M; Latkin CA; Hall BJ; Nguyen CT; Ha GH; Nguyen NB; Ho CSH; Ho RCM
    Subst Abuse Treat Prev Policy; 2019 May; 14(1):21. PubMed ID: 31101059
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.
    Burlew AK; Weekes JC; Montgomery L; Feaster DJ; Robbins MS; Rosa CL; Ruglass LM; Venner KL; Wu LT
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):324-32. PubMed ID: 21854274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sex-gender differences in drug abuse: a shift in the burden of proof?
    Wetherington CL
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):411-7. PubMed ID: 17924775
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Addiction treatment outcomes, process and change: Texas Institute of Behavioral Research at Texas Christian University.
    Simpson DD; Joe GW; Dansereau DF; Flynn PM
    Addiction; 2011 Oct; 106(10):1733-40. PubMed ID: 20840168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bridging the gap between the neurocognitive lab and the addiction clinic.
    Franken IHA; van de Wetering BJM
    Addict Behav; 2015 May; 44():108-114. PubMed ID: 25500167
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Personal and contextual factors in substance abuse treatment among racial and ethnic minorities: Studies from the NIDA clinical trials network.
    Burlew AK; Sanchez K
    J Ethn Subst Abuse; 2017; 16(4):401-403. PubMed ID: 29236626
    [No Abstract]   [Full Text] [Related]  

  • 75. Society of Behavioral Medicine (SBM) position statement: End the fatal paradox: change the names of our Federal Institutes on Addiction.
    Kelly JF; Earnshaw V
    Transl Behav Med; 2021 May; 11(5):1160-1161. PubMed ID: 33258477
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice.
    Carroll KM
    Ann N Y Acad Sci; 2014 Oct; 1327(1):94-111. PubMed ID: 25204847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial.
    Garner BR; Gotham HJ; Tueller SJ; Ball EL; Kaiser D; Stilen P; Speck K; Vandersloot D; Rieckmann TR; Chaple M; Martin EG; Martino S
    Addict Sci Clin Pract; 2017 Nov; 12(1):31. PubMed ID: 29149914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Training in addiction medicine should be standardised and scaled up.
    Klimas J
    BMJ; 2015 Jul; 351():h4027. PubMed ID: 26220548
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Realising the technological promise of smartphones in addiction research and treatment: An ethical review.
    Capon H; Hall W; Fry C; Carter A
    Int J Drug Policy; 2016 Oct; 36():47-57. PubMed ID: 27455467
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.